Incretin Hormones in Obesity and Related Cardiometabolic Disorders: The Clinical Perspective
出版年份 2021 全文链接
标题
Incretin Hormones in Obesity and Related Cardiometabolic Disorders: The Clinical Perspective
作者
关键词
-
出版物
Nutrients
Volume 13, Issue 2, Pages 351
出版商
MDPI AG
发表日期
2021-01-25
DOI
10.3390/nu13020351
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Native, Intact Glucagon-Like Peptide 1 Is a Natural Suppressor of Thrombus Growth Under Physiological Flow Conditions
- (2020) Marieke Sternkopf et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Efficacy and safety of anti-hyperglycaemic drugs in patients with non-alcoholic fatty liver disease with or without diabetes: An updated systematic review of randomized controlled trials
- (2020) A. Mantovani et al. DIABETES & METABOLISM
- No Acute Effects of Exogenous Glucose-Dependent Insulinotropic Polypeptide on Energy Intake, Appetite, or Energy Expenditure When Added to Treatment With a Long-Acting Glucagon-Like Peptide 1 Receptor Agonist in Men With Type 2 Diabetes
- (2020) Natasha C. Bergmann et al. DIABETES CARE
- Semaglutide (SUSTAIN and PIONEER) reduces cardiovascular events in type 2 diabetes across varying cardiovascular risk
- (2020) Mansoor Husain et al. DIABETES OBESITY & METABOLISM
- Glucose-dependent insulinotropic peptide and risk of cardiovascular events and mortality: a prospective study
- (2020) Amra Jujić et al. DIABETOLOGIA
- Effects of Novel Dual GIP and GLP-1 Receptor Agonist Tirzepatide on Biomarkers of Nonalcoholic Steatohepatitis in Patients With Type 2 Diabetes
- (2020) Mark L. Hartman et al. DIABETES CARE
- GIP as a therapeutic target in diabetes and obesity: insight from incretin co-agonists
- (2020) Jens Juul Holst et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- A novel thrombin-based triagonist with diabetes-protective and weight-lowering potential
- (2020) Jingyu Zhang et al. LIFE SCIENCES
- Type 2 Diabetes Mellitus: A Review of Multi-Target Drugs
- (2020) Angelica Artasensi et al. MOLECULES
- Liraglutide Attenuates Non-Alcoholic Fatty Liver Disease in Mice by Regulating the Local Renin-Angiotensin System
- (2020) Mengying Yang et al. Frontiers in Pharmacology
- A Systematic Review of Newer Antidiabetic Agents in the Treatment of Nonalcoholic Fatty Liver Disease
- (2020) John A. Dougherty et al. ANNALS OF PHARMACOTHERAPY
- Obesity in adults: a clinical practice guideline
- (2020) Sean Wharton et al. CANADIAN MEDICAL ASSOCIATION JOURNAL
- Cardiovascular Outcomes Trials with Glucagon‐like Peptide‐1 Receptor Agonists: A Comparison of Study Designs, Populations, and Results
- (2020) Kevin M. Pantalone et al. DIABETES OBESITY & METABOLISM
- Effects and Safety of Sitagliptin in Non-Alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis
- (2020) Yuhan Zhang et al. HORMONE AND METABOLIC RESEARCH
- Use of incretin-based medications: what do current international recommendations suggest with respect to GLP-1 receptor agonists and DPP-4 inhibitors?
- (2020) Melanie J. Davies et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- GLP-1 Analogues as a Complementary Therapy in Patients after Metabolic Surgery: a Systematic Review and Qualitative Synthesis
- (2020) Romano Schneider et al. OBESITY SURGERY
- The dual glucose‐dependent insulinotropic peptide and glucagon‐like peptide‐1 receptor agonist, tirzepatide, improves lipoprotein biomarkers associated with insulin resistance and cardiovascular risk in patients with type 2 diabetes
- (2020) Jonathan M. Wilson et al. DIABETES OBESITY & METABOLISM
- Antidiabetic drugs and non-alcoholic fatty liver disease: A systematic review, meta-analysis and evidence map
- (2020) Jai Kumar et al. DIGESTIVE AND LIVER DISEASE
- Pathophysiology of Type 2 Diabetes Mellitus
- (2020) Unai Galicia-Garcia et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Cardiovascular outcome trials in obesity: A review
- (2020) John P.H. Wilding et al. Obesity Reviews
- GLP-1 receptor agonists in the treatment of type 2 diabetes: role and clinical experience to date
- (2020) Stephen A. Brunton et al. POSTGRADUATE MEDICINE
- Nutrient consumption-dependent association of a glucagon-like peptide-1 receptor gene polymorphism with insulin secretion
- (2020) Yuki Nishiya et al. Scientific Reports
- Glucagon-like peptide-1 receptor co-agonists for treating metabolic disease
- (2020) Laurie L. Baggio et al. Molecular Metabolism
- Glucose-Dependent Insulinotropic Peptide in the High-Normal Range Is Associated With Increased Carotid Intima-Media Thickness
- (2020) Amra Jujić et al. DIABETES CARE
- New prospects for incretin‐related drugs in the treatment of type 2 diabetes
- (2020) Tomohiko Kimura et al. Journal of Diabetes Investigation
- The Role of Tirzepatide, Dual GIP and GLP-1 Receptor Agonist, in the Management of Type 2 Diabetes: The SURPASS Clinical Trials
- (2020) Thinzar Min et al. Diabetes Therapy
- Efficacy and Cardiovascular Safety of DPP-4 Inhibitors
- (2020) Nikhila A. Subrahmanyan et al. Current Drug Safety
- Ten years of experience with DPP-4 inhibitors for the treatment of type 2 diabetes mellitus
- (2019) Giorgio Sesti et al. ACTA DIABETOLOGICA
- Effects of lixisenatide on postprandial blood pressure, gastric emptying and glycemia in health and type 2 diabetes
- (2019) Karen L. Jones et al. DIABETES OBESITY & METABOLISM
- Identification of 28 new susceptibility loci for type 2 diabetes in the Japanese population
- (2019) Ken Suzuki et al. NATURE GENETICS
- Effects of combined GIP and GLP-1 infusion on energy intake, appetite and energy expenditure in overweight/obese individuals: a randomised, crossover study
- (2019) Natasha C. Bergmann et al. DIABETOLOGIA
- Evaluation of a rare glucose-dependent insulinotropic polypeptide receptor variant in a patient with diabetes
- (2019) Simon F. Jacobi et al. DIABETES OBESITY & METABOLISM
- Meta-analyses of the effects of DPP-4 inhibitors, SGLT2 inhibitors and GLP1 receptor analogues on cardiovascular death, myocardial infarction, stroke and hospitalization for heart failure
- (2019) Binayak Sinha et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- A double-blind, placebo-controlled, randomised trial to assess the effect of liraglutide on ectopic fat accumulation in South Asian type 2 diabetes patients
- (2019) Huub J. van Eyk et al. Cardiovascular Diabetology
- Body weight management and safety with efpeglenatide in adults without diabetes: a phase II randomized study
- (2019) Richard E. Pratley et al. DIABETES OBESITY & METABOLISM
- Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial
- (2019) Hertzel C Gerstein et al. LANCET
- Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
- (2019) Mansoor Husain et al. NEW ENGLAND JOURNAL OF MEDICINE
- Consensus Recommendations on GLP-1 RA Use in the Management of Type 2 Diabetes Mellitus: South Asian Task Force
- (2019) Sanjay Kalra et al. Diabetes Therapy
- Clinical Use of DPP-4 Inhibitors
- (2019) Baptist Gallwitz Frontiers in Endocrinology
- Mechanism of Glucagon-Like Peptide 1 Improvements in Type 2 Diabetes Mellitus and Obesity
- (2019) Eric Nolen-Doerr et al. Current Obesity Reports
- Incretins in obesity and diabetes
- (2019) Chee W. Chia et al. Annals of the New York Academy of Sciences
- Glucose-Dependent Insulinotropic Polypeptide Receptor-Expressing Cells in the Hypothalamus Regulate Food Intake
- (2019) Alice E. Adriaenssens et al. Cell Metabolism
- GLP-1: Molecular mechanisms and outcomes of a complex signaling system
- (2019) Nicholas K. Smith et al. NEUROCHEMISTRY INTERNATIONAL
- Glucagon-like peptide 1 (GLP-1)
- (2019) T.D. Müller et al. Molecular Metabolism
- Glucose-dependent insulinotropic polypeptide (GIP) and cardiovascular disease
- (2019) Sebastian M. Heimbürger et al. PEPTIDES
- GIP analogues and the treatment of obesity-diabetes
- (2019) Clifford J. Bailey PEPTIDES
- The influence of Glucose-dependent Insulinotropic Polypeptide (GIP) on human adipose tissue and fat metabolism: Implications for obesity, type 2 diabetes and Non-Alcoholic Fatty Liver Disease (NAFLD)
- (2019) Sravan K. Thondam et al. PEPTIDES
- Physiological roles of the GIP receptor in murine brown adipose tissue
- (2019) Jacqueline L. Beaudry et al. Molecular Metabolism
- 2019 update to: Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
- (2019) John B. Buse et al. DIABETOLOGIA
- Cardiovascular biology of the GIP receptor
- (2019) Amanda A. Greenwell et al. PEPTIDES
- Molecular interactions of full-length and truncated GIP peptides with the GIP receptor – A comprehensive review
- (2019) Maria Buur Nordskov Gabe et al. PEPTIDES
- Liraglutide Improves Non-Alcoholic Fatty Liver Disease In Diabetic Mice By Modulating Inflammatory Signaling Pathways
- (2019) Ying Luo et al. Drug Design Development and Therapy
- Glucagon-like peptide-1 receptor and sarcoglycan delta genetic variants can affect cardiovascular risk in chronic kidney disease patients under hemodialysis
- (2019) Annalisa Terranegra et al. Clinical Kidney Journal
- Glucagon-like peptide-1 regulates brown adipose tissue thermogenesis via the gut-brain axis in rats
- (2018) Jean-Philippe Krieger et al. AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY
- GLP-1 receptor agonists and reduction of cardiometabolic risk: Potential underlying mechanisms
- (2018) Manfredi Rizzo et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Semaglutide: Review and Place in Therapy for Adults with Type 2 Diabetes
- (2018) Ronald M. Goldenberg et al. Canadian Journal of Diabetes
- GLP-1 Receptor Agonists and Cardiovascular Disease: a Meta-Analysis of Recent Cardiac Outcome Trials
- (2018) Xiaoming Jia et al. CARDIOVASCULAR DRUGS AND THERAPY
- Nonsynonymous Variants inPAX4andGLP1Rare Associated with Type 2 Diabetes in an East Asian Population
- (2018) Soo Heon Kwak et al. DIABETES
- Endogenous GLP-1 alters postprandial functional connectivity between homeostatic and reward-related brain regions involved in regulation of appetite in healthy lean males: A pilotstudy
- (2018) Anne Christin Meyer-Gerspach et al. DIABETES OBESITY & METABOLISM
- Incretin hormones: Their role in health and disease
- (2018) Michael A. Nauck et al. DIABETES OBESITY & METABOLISM
- The effect of glucagon-like peptide 1 and glucagon-like peptide 1 receptor agonists on energy expenditure: A systematic review and meta-analysis
- (2018) Michel Garcia Maciel et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Incretin-based therapy in type 2 diabetes: An evidence based systematic review and meta-analysis
- (2018) Greer Waldrop et al. JOURNAL OF DIABETES AND ITS COMPLICATIONS
- MEDI0382, a GLP-1 and glucagon receptor dual agonist, in obese or overweight patients with type 2 diabetes: a randomised, controlled, double-blind, ascending dose and phase 2a study
- (2018) Philip Ambery et al. LANCET
- Allelic variant in the glucagon-like peptide 1 receptor gene associated with greater effect of liraglutide and exenatide on gastric emptying: A pilot pharmacogenetics study
- (2018) V. Chedid et al. NEUROGASTROENTEROLOGY AND MOTILITY
- Newer GLP-1 receptor agonists and obesity-diabetes
- (2018) Emily Brown et al. PEPTIDES
- Novel role of GLP-1 receptor signaling in energy expenditure during chronic high fat diet feeding in rats
- (2018) Jean-Philippe Krieger et al. PHYSIOLOGY & BEHAVIOR
- Incretin responses to oral glucose and mixed meal tests and changes in fasting glucose levels during 7 years of follow-up: The Hoorn Meal Study
- (2018) A. D. M. Koopman et al. PLoS One
- Loss of dorsomedial hypothalamic GLP-1 signaling reduces BAT thermogenesis and increases adiposity
- (2018) Shin J. Lee et al. Molecular Metabolism
- The Origin and Understanding of the Incretin Concept
- (2018) Jens F. Rehfeld Frontiers in Endocrinology
- Current guidelines for the management of non-alcoholic fatty liver disease: A systematic review with comparative analysis
- (2018) Simona Leoni et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Polymorphisms in the Glucagon-Like Peptide 1 Receptor (GLP-1R) Gene Are Associated with the Risk of Coronary Artery Disease in Chinese Han Patients with Type 2 Diabetes Mellitus: A Case-Control Study
- (2018) Xiaowei Ma et al. Journal of Diabetes Research
- Pharmacogenetics of type 2 diabetes mellitus, the route toward tailored medicine
- (2018) Gaia Chiara Mannino et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
- GLP-1 receptor agonists and cardiovascular outcome trials: An update
- (2018) Eirini Andrikou et al. Hellenic Journal of Cardiology
- Modulation of Insulin Resistance in NAFLD
- (2018) Reenam Khan et al. HEPATOLOGY
- Efficacy and safety of LY3298176, a novel dual GIP and GLP-1 receptor agonist, in patients with type 2 diabetes: a randomised, placebo-controlled and active comparator-controlled phase 2 trial
- (2018) Juan Pablo Frias et al. LANCET
- Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial
- (2018) Adrian F Hernandez et al. LANCET
- Obesity and nonalcoholic fatty liver disease: From pathophysiology to therapeutics
- (2018) Stergios A. Polyzos et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Pharmacotherapy of obesity: Available medications and drugs under investigation
- (2018) Eleni Pilitsi et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- LY3298176, a novel dual GIP and GLP-1 receptor agonist for the treatment of type 2 diabetes mellitus: From discovery to clinical proof of concept
- (2018) Tamer Coskun et al. Molecular Metabolism
- Association of incretin receptors genetic polymorphisms with type 2 diabetes mellitus in Egyptian patients
- (2017) Sally M. Shalaby et al. JOURNAL OF GENE MEDICINE
- Protein-altering variants associated with body mass index implicate pathways that control energy intake and expenditure in obesity
- (2017) Valérie Turcot et al. NATURE GENETICS
- Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 Diabetes
- (2017) Rury R. Holman et al. NEW ENGLAND JOURNAL OF MEDICINE
- The cardiovascular safety trials of DPP-4 inhibitors, GLP-1 agonists, and SGLT2 inhibitors
- (2017) Matthew H. Secrest et al. TRENDS IN CARDIOVASCULAR MEDICINE
- Novel Common Variants Associated with Obesity and Type 2 Diabetes Detected Using a cFDR Method
- (2017) Qiang Zhang et al. Scientific Reports
- The effect of glucose-dependent insulinotropic polypeptide (GIP) variants on visceral fat accumulation in Han Chinese populations
- (2017) T Wang et al. Nutrition & Diabetes
- Glucagon-Like Peptide 1: A Predictor of Type 2 Diabetes?
- (2017) Matthias Ploug Larsen et al. Journal of Diabetes Research
- Elevated hepatic DPP4 activity promotes insulin resistance and non-alcoholic fatty liver disease
- (2017) Christian Baumeier et al. Molecular Metabolism
- Monomeric GLP-1/GIP/glucagon triagonism corrects obesity, hepatosteatosis, and dyslipidemia in female mice
- (2017) Sigrid Jall et al. Molecular Metabolism
- Evaluation of Weight Loss and Adipocytokine Levels after Two Hypocaloric Diets with Different Macronutrient Distribution in Obese Subjects with the rs6923761 Gene Variant of Glucagon-Like Peptide 1 Receptor
- (2017) Daniel Antonio de Luis et al. ANNALS OF NUTRITION AND METABOLISM
- The Cardiovascular Biology of Glucagon-like Peptide-1
- (2016) Daniel J. Drucker Cell Metabolism
- Glucagon-Like Peptide 1 Receptor Activation Attenuates Platelet Aggregation and Thrombosis
- (2016) Alison Cameron-Vendrig et al. DIABETES
- Diabetes and obesity treatment based on dual incretin receptor activation: ‘twincretins’
- (2016) M. A. Skow et al. DIABETES OBESITY & METABOLISM
- Efficacy and safety of liraglutide 3.0 mg for weight management are similar across races: subgroup analysis across the SCALE and phase II randomized trials
- (2016) J. Ard et al. DIABETES OBESITY & METABOLISM
- GLP-1 receptors exist in the parietal cortex, hypothalamus and medulla of human brains and the GLP-1 analogue liraglutide alters brain activity related to highly desirable food cues in individuals with diabetes: a crossover, randomised, placebo-controlled trial
- (2016) Olivia M. Farr et al. DIABETOLOGIA
- EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease
- (2016) et al. DIABETOLOGIA
- Pathophysiology of Non Alcoholic Fatty Liver Disease
- (2016) Salvatore Petta et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Obesity: An overview of possible role(s) of gut hormones, lipid sensing and gut microbiota
- (2016) Alok Kumar Mishra et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
- (2016) Steven P. Marso et al. NEW ENGLAND JOURNAL OF MEDICINE
- Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
- (2016) Steven P. Marso et al. NEW ENGLAND JOURNAL OF MEDICINE
- The incretin system ABCs in obesity and diabetes - novel therapeutic strategies for weight loss and beyond
- (2016) A. L. João et al. Obesity Reviews
- A genomic approach to therapeutic target validation identifies a glucose-lowering GLP1R variant protective for coronary heart disease
- (2016) Robert A. Scott et al. Science Translational Medicine
- The incretin effect in healthy individuals and those with type 2 diabetes: physiology, pathophysiology, and response to therapeutic interventions
- (2016) Michael A Nauck et al. Lancet Diabetes & Endocrinology
- Physical activity and genetic predisposition to obesity in a multiethnic longitudinal study
- (2016) Hudson Reddon et al. Scientific Reports
- Postprandial glucagon-like peptide-1 secretion is increased during the progression of glucose intolerance and obesity in high-fat/high-sucrose diet-fed rats
- (2015) Shingo Nakajima et al. BRITISH JOURNAL OF NUTRITION
- The glucagon-like peptide-1 (GLP-1) receptor agonist, exenatide, inhibits small intestinal motility, flow, transit and absorption of glucose in healthy subjects and patients with type 2 diabetes: a randomised controlled trial.
- (2015) Sony S. Thazhath et al. DIABETES
- Exenatide Regulates Cerebral Glucose Metabolism in Brain Areas Associated With Glucose Homeostasis and Reward System
- (2015) Giuseppe Daniele et al. DIABETES
- Liraglutide Reduces CNS Activation in Response to Visual Food Cues Only After Short-term Treatment in Patients With Type 2 Diabetes
- (2015) Jennifer S. ten Kulve et al. DIABETES CARE
- Brain reward-system activation in response to anticipation and consumption of palatable food is altered by glucagon-like peptide-1 receptor activation in humans
- (2015) L. van Bloemendaal et al. DIABETES OBESITY & METABOLISM
- Contribution of brown adipose tissue activity to the control of energy balance by GLP-1 receptor signalling in mice
- (2015) Kristy M. Heppner et al. DIABETOLOGIA
- Genetic variability in GLP-1 receptor is associated with inter-individual differences in weight lowering potential of liraglutide in obese women with PCOS: a pilot study
- (2015) Mojca Jensterle et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Genetic studies of body mass index yield new insights for obesity biology
- (2015) Adam E. Locke et al. NATURE
- Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome
- (2015) Marc A. Pfeffer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Emotional eating is associated with increased brain responses to food-cues and reduced sensitivity to GLP-1 receptor activation
- (2015) Liselotte van Bloemendaal et al. Obesity
- European Guidelines for Obesity Management in Adults
- (2015) Volkan Yumuk et al. Obesity Facts
- Physiology of Proglucagon Peptides: Role of Glucagon and GLP-1 in Health and Disease
- (2015) Darleen A. Sandoval et al. PHYSIOLOGICAL REVIEWS
- Replication Study in a Japanese Population to Evaluate the Association between 10 SNP Loci, Identified in European Genome-Wide Association Studies, and Type 2 Diabetes
- (2015) Ren Matsuba et al. PLoS One
- Low-frequency and rare exome chip variants associate with fasting glucose and type 2 diabetes susceptibility
- (2015) Jennifer Wessel et al. Nature Communications
- Polymorphisms of GLP-1 Receptor Gene and Response to GLP-1 Analogue in Patients with Poorly Controlled Type 2 Diabetes
- (2015) Chia-Hung Lin et al. Journal of Diabetes Research
- Effects of a high-protein/low-carbohydrate versus a standard hypocaloric diet on adipocytokine levels and cardiovascular risk factors during 9 months, role of rs6923761 gene variant of glucagon-like peptide 1 receptor
- (2015) D. A. de Luis et al. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
- Relation of the rs6923761 Gene Variant in Glucagon-Like Peptide 1 Receptor to Metabolic Syndrome in Obese Subjects
- (2014) Daniel Antonio de Luis et al. ANNALS OF NUTRITION AND METABOLISM
- Role of the rs6923761 Gene Variant in Glucagon-Like Peptide 1 Receptor Gene on Cardiovascular Risk Factors and Weight Loss after Biliopancreatic Diversion Surgery
- (2014) Daniel Antonio de Luis et al. ANNALS OF NUTRITION AND METABOLISM
- Changes in liraglutide-induced body composition are related to modifications in plasma cardiac natriuretic peptides levels in obese type 2 diabetic patients
- (2014) Chun-Jun Li et al. Cardiovascular Diabetology
- GLP-1 Plays a Limited Role in Improved Glycemia Shortly After Roux-en-Y Gastric Bypass: A Comparison With Intensive Lifestyle Modification
- (2014) Marion L. Vetter et al. DIABETES
- Chronic Reduction of GIP Secretion Alleviates Obesity and Insulin Resistance Under High-Fat Diet Conditions
- (2014) D. Nasteska et al. DIABETES
- GLP-1 Agonism Stimulates Brown Adipose Tissue Thermogenesis and Browning Through Hypothalamic AMPK
- (2014) D. Beiroa et al. DIABETES
- Circulating Glucagon-like Peptide-1 (GLP-1) Inhibits Eating in Male Rats by Acting in the Hindbrain and Without Inducing Avoidance
- (2014) Mukesh Punjabi et al. ENDOCRINOLOGY
- GLP-1 receptor agonists vs. DPP-4 inhibitors for type 2 diabetes: is one approach more successful or preferable than the other?
- (2014) S. Brunton INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- The arcuate nucleus mediates GLP-1 receptor agonist liraglutide-dependent weight loss
- (2014) Anna Secher et al. JOURNAL OF CLINICAL INVESTIGATION
- Relation of the rs6923761 Gene Variant in Glucagon-Like Peptide 1 Receptor with Weight, Cardiovascular Risk Factor, and Serum Adipokine Levels in Obese Female Subjects
- (2014) Daniel Antonio de Luis et al. JOURNAL OF CLINICAL LABORATORY ANALYSIS
- A rationally designed monomeric peptide triagonist corrects obesity and diabetes in rodents
- (2014) Brian Finan et al. NATURE MEDICINE
- Laparoscopic Sleeve Gastrectomy Versus Single Anastomosis (Mini-) Gastric Bypass for the Treatment of Type 2 Diabetes Mellitus: 5-Year Results of a Randomized Trial and Study of Incretin Effect
- (2014) Wei-Jei Lee et al. OBESITY SURGERY
- Weight loss effect of glucagon-like peptide-1 mimetics on obese/overweight adults without diabetes: A systematic review and meta-analysis of randomized controlled trials胰高血糖素样肽-1类似物对非糖尿病肥胖/超重成人的减重作用:一篇对随机对照试验进行的系统评价及meta分析
- (2014) Fang Zhang et al. Journal of Diabetes
- Cardiovascular risk factors and adipocytokines levels after two hypocaloric diets with different fat distribution in obese subjects and rs6923761 gene variant of glucagon-like peptide 1 receptor
- (2014) Daniel Antonio de Luis et al. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
- Effect of rs6923761 gene variant of glucagon-like peptide 1 receptor on metabolic response and weight loss after a 3-month intervention with a hypocaloric diet
- (2014) Daniel Antonio de Luis et al. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
- Glucagon-like peptide-1 (GLP-1) and its split products GLP-1(9-37) and GLP-1(28-37) stabilize atherosclerotic lesions in apoe−/− mice
- (2013) Mathias Burgmaier et al. ATHEROSCLEROSIS
- Pharmacology, Physiology, and Mechanisms of Incretin Hormone Action
- (2013) Jonathan E. Campbell et al. Cell Metabolism
- Contribution of Endogenous Glucagon-Like Peptide 1 to Glucose Metabolism After Roux-en-Y Gastric Bypass
- (2013) M. Shah et al. DIABETES
- Comparative Effects of Prolonged and Intermittent Stimulation of the Glucagon-Like Peptide 1 Receptor on Gastric Emptying and Glycemia
- (2013) M. M. Umapathysivam et al. DIABETES
- GLP-1 Action and Glucose Tolerance in Subjects With Remission of Type 2 Diabetes After Gastric Bypass Surgery
- (2013) A. Jimenez et al. DIABETES CARE
- Exenatide-Induced Reduction in Energy Intake Is Associated With Increase in Hypothalamic Connectivity
- (2013) H. Schlogl et al. DIABETES CARE
- Secretion of Glucose-Dependent Insulinotropic Polypeptide in Patients With Type 2 Diabetes: Systematic review and meta-analysis of clinical studies
- (2013) S. Calanna et al. DIABETES CARE
- The once-daily human GLP-1 analogue liraglutide impacts appetite and energy intake in patients with type 2 diabetes after short-term treatment
- (2013) A. Flint et al. DIABETES OBESITY & METABOLISM
- Incretins: Their physiology and application in the treatment of diabetes mellitus
- (2013) Hale M. Tasyurek et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
- Secretion of glucagon-like peptide-1 in patients with type 2 diabetes mellitus: systematic review and meta-analyses of clinical studies
- (2013) S. Calanna et al. DIABETOLOGIA
- Functional Analysis of Seven Genes Linked to Body Mass Index and Adiposity by Genome-Wide Association Studies: A Review
- (2013) John R. Speakman HUMAN HEREDITY
- Effects of the once-daily GLP-1 analog liraglutide on gastric emptying, glycemic parameters, appetite and energy metabolism in obese, non-diabetic adults
- (2013) J van Can et al. INTERNATIONAL JOURNAL OF OBESITY
- Genetic association analysis of 30 genes related to obesity in a European American population
- (2013) P Li et al. INTERNATIONAL JOURNAL OF OBESITY
- Obesity: The Gateway to Ill Health - an EASO Position Statement on a Rising Public Health, Clinical and Scientific Challenge in Europe
- (2013) Gema Frühbeck et al. Obesity Facts
- Physiology of incretins and loss of incretin effect in type 2 diabetes and obesity
- (2013) Giuseppina Opinto et al. ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY
- Effects of Roux-en-Y gastric bypass on energy and glucose homeostasis are preserved in two mouse models of functional glucagon-like peptide-1 deficiency
- (2013) Mohamad Mokadem et al. Molecular Metabolism
- Weight-loss diets modify glucose-dependent insulinotropic polypeptide receptor rs2287019 genotype effects on changes in body weight, fasting glucose, and insulin resistance: the Preventing Overweight Using Novel Dietary Strategies trial
- (2012) Qibin Qi et al. AMERICAN JOURNAL OF CLINICAL NUTRITION
- Obesity susceptibility loci and dietary intake in the Look AHEAD Trial
- (2012) Jeanne M McCaffery et al. AMERICAN JOURNAL OF CLINICAL NUTRITION
- Direct Control of Brown Adipose Tissue Thermogenesis by Central Nervous System Glucagon-Like Peptide-1 Receptor Signaling
- (2012) S. H. Lockie et al. DIABETES
- Genetic Variation in the Glucose-Dependent Insulinotropic Polypeptide Receptor Modifies the Association between Carbohydrate and Fat Intake and Risk of Type 2 Diabetes in the Malmö Diet and Cancer Cohort
- (2012) Emily Sonestedt et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- The Glucagon-Like Peptide 1 (GLP-1) Analogue, Exendin-4, Decreases the Rewarding Value of Food: A New Role for Mesolimbic GLP-1 Receptors
- (2012) S. L. Dickson et al. JOURNAL OF NEUROSCIENCE
- Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes
- (2012) NATURE GENETICS
- The effect of glucagon-like peptide 1 on cardiovascular risk
- (2012) Jacob Sivertsen et al. Nature Reviews Cardiology
- GLP-1 Receptor Agonist and Non-Alcoholic Fatty Liver Disease
- (2012) Jinmi Lee et al. Diabetes & Metabolism Journal
- Rapid Tachyphylaxis of the Glucagon-Like Peptide 1-Induced Deceleration of Gastric Emptying in Humans
- (2011) M. A. Nauck et al. DIABETES
- Impaired incretin effect and fasting hyperglucagonaemia characterizing type 2 diabetic subjects are early signs of dysmetabolism in obesity
- (2011) F. K. Knop et al. DIABETES OBESITY & METABOLISM
- Glucagon-like peptide-1 receptor activation stimulates hepatic lipid oxidation and restores hepatic signalling alteration induced by a high-fat diet in nonalcoholic steatohepatitis
- (2011) Gianluca Svegliati-Baroni et al. LIVER INTERNATIONAL
- Comparative Effects of the Long-Acting GLP-1 Receptor Ligands, Liraglutide and Exendin-4, on Food Intake and Body Weight Suppression in Rats
- (2011) Matthew R. Hayes et al. Obesity
- Obesity - an indication for GLP-1 treatment? Obesity pathophysiology and GLP-1 treatment potential
- (2011) S. S. Torekov et al. Obesity Reviews
- Differential processing of pro-glucose-dependent insulinotropic polypeptide in gut
- (2010) Yukihiro Fujita et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Detailed Physiologic Characterization Reveals Diverse Mechanisms for Novel Genetic Loci Regulating Glucose and Insulin Metabolism in Humans
- (2010) E. Ingelsson et al. DIABETES
- Secretion of glucagon-like peptide-1 (GLP-1) in type 2 diabetes: what is up, what is down?
- (2010) M. A. Nauck et al. DIABETOLOGIA
- Molecular mechanisms underlying nutrient-stimulated incretin secretion
- (2010) Helen E. Parker et al. EXPERT REVIEWS IN MOLECULAR MEDICINE
- Glucagon-like peptide-1 receptor is present on human hepatocytes and has a direct role in decreasing hepatic steatosis in vitro by modulating elements of the insulin signaling pathway
- (2010) Nitika Arora Gupta et al. HEPATOLOGY
- Effect of Administration Time of Exenatide on Satiety Responses, Blood Glucose, and Adverse Events in Healthy Volunteers
- (2010) Nicole R. Pinelli et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index
- (2010) Elizabeth K Speliotes et al. NATURE GENETICS
- Genetic variation in GIPR influences the glucose and insulin responses to an oral glucose challenge
- (2010) Richa Saxena et al. NATURE GENETICS
- Differential incretin effects of GIP and GLP-1 on gastric emptying, appetite, and insulin-glucose homeostasis
- (2010) T. Edholm et al. NEUROGASTROENTEROLOGY AND MOTILITY
- Variants from GIPR, TCF7L2, DGKB, MADD, CRY2, GLIS3, PROX1, SLC30A8 and IGF1 Are Associated with Glucose Metabolism in the Chinese
- (2010) Cheng Hu et al. PLoS One
- GIP and GLP-1, the two incretin hormones: Similarities and differences
- (2010) Yutaka Seino et al. Journal of Diabetes Investigation
- Prolonged saturated fat–induced, glucose-dependent insulinotropic polypeptide elevation is associated with adipokine imbalance and liver injury in nonalcoholic steatohepatitis: dysregulated enteroadipocyte axis as a novel feature of fatty liver
- (2009) Giovanni Musso et al. AMERICAN JOURNAL OF CLINICAL NUTRITION
- On the role of glucose-dependent insulintropic polypeptide in postprandial metabolism in humans
- (2009) Meena Asmar et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Effects of peripheral administration of synthetic human glucose-dependent insulinotropic peptide (GIP) on energy expenditure and subjective appetite sensations in healthy normal weight subjects and obese patients with type 2 diabetes
- (2009) C. Daousi et al. CLINICAL ENDOCRINOLOGY
- Endogenous Glucagon-Like Peptide-1 Slows Gastric Emptying in Healthy Subjects, Attenuating Postprandial Glycemia
- (2009) Adam M. Deane et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Effect of exenatide on gastric emptying and relationship to postprandial glycemia in type 2 diabetes
- (2008) Helle Linnebjerg et al. REGULATORY PEPTIDES
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now